Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2014 10
2015 6
2016 5
2017 8
2018 5
2019 5
2020 4
2021 6
2022 4
2023 1
2024 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

50 results

Results by year

Filters applied: . Clear all
Page 1
MYC regulates the antitumor immune response through CD47 and PD-L1.
Casey SC, Tong L, Li Y, Do R, Walz S, Fitzgerald KN, Gouw AM, Baylot V, Gütgemann I, Eilers M, Felsher DW. Casey SC, et al. Science. 2016 Apr 8;352(6282):227-31. doi: 10.1126/science.aac9935. Epub 2016 Mar 10. Science. 2016. PMID: 26966191 Free PMC article.
MYC-driven synthesis of Siglec ligands is a glycoimmune checkpoint.
Smith BAH, Deutzmann A, Correa KM, Delaveris CS, Dhanasekaran R, Dove CG, Sullivan DK, Wisnovsky S, Stark JC, Pluvinage JV, Swaminathan S, Riley NM, Rajan A, Majeti R, Felsher DW, Bertozzi CR. Smith BAH, et al. Proc Natl Acad Sci U S A. 2023 Mar 14;120(11):e2215376120. doi: 10.1073/pnas.2215376120. Epub 2023 Mar 10. Proc Natl Acad Sci U S A. 2023. PMID: 36897988 Free PMC article.
Metabolic vulnerabilities of MYC-induced cancer.
Gouw AM, Toal GG, Felsher DW. Gouw AM, et al. Oncotarget. 2016 May 24;7(21):29879-80. doi: 10.18632/oncotarget.7223. Oncotarget. 2016. PMID: 26863454 Free PMC article. No abstract available.
MYC: Master Regulator of Immune Privilege.
Casey SC, Baylot V, Felsher DW. Casey SC, et al. Trends Immunol. 2017 Apr;38(4):298-305. doi: 10.1016/j.it.2017.01.002. Epub 2017 Feb 21. Trends Immunol. 2017. PMID: 28233639 Free PMC article. Review.
Oncogene addiction: resetting the safety switch?
Li Y, Choi PS, Felsher DW. Li Y, et al. Oncotarget. 2014 Sep 30;5(18):7986-7. doi: 10.18632/oncotarget.2474. Oncotarget. 2014. PMID: 25275297 Free PMC article. No abstract available.
Inactivation of MYC reverses tumorigenesis.
Li Y, Casey SC, Felsher DW. Li Y, et al. J Intern Med. 2014 Jul;276(1):52-60. doi: 10.1111/joim.12237. J Intern Med. 2014. PMID: 24645771 Free PMC article. Review.
Cancer prevention and therapy through the modulation of the tumor microenvironment.
Casey SC, Amedei A, Aquilano K, Azmi AS, Benencia F, Bhakta D, Bilsland AE, Boosani CS, Chen S, Ciriolo MR, Crawford S, Fujii H, Georgakilas AG, Guha G, Halicka D, Helferich WG, Heneberg P, Honoki K, Keith WN, Kerkar SP, Mohammed SI, Niccolai E, Nowsheen S, Vasantha Rupasinghe HP, Samadi A, Singh N, Talib WH, Venkateswaran V, Whelan RL, Yang X, Felsher DW. Casey SC, et al. Semin Cancer Biol. 2015 Dec;35 Suppl(Suppl):S199-S223. doi: 10.1016/j.semcancer.2015.02.007. Epub 2015 Apr 10. Semin Cancer Biol. 2015. PMID: 25865775 Free PMC article. Review.
50 results